The global Lennox-Gastaut syndrome therapeutics market is witnessing a period of significant growth. This trend can be attributed to several factors, including an growing prevalence of Lennox-Gastaut syndrome globally and advancements in treatment approaches. The market is fueled by a growing demand for effective therapies to treat the complex mani